📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ag85A-specific CD4+ T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties. (2018)

First Author: Metcalfe HJ

Attributed to: Host responses underlying immunity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2018.03.068

PubMed Identifier: 29655632

Publication URI: http://europepmc.org/abstract/MED/29655632

Type: Journal Article/Review

Volume: 36

Parent Publication: Vaccine

Issue: 20

ISSN: 0264-410X